US Patent Issued to Evecxia Therapeutics on Sept. 9 for "Method of enhancing 5-hydroxytryptophan (5-HTP) exposure" (North Carolina Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,163, issued on Sept. 9, was assigned to Evecxia Therapeutics Inc. (Research Triangle Park, N.C.).

"Method of enhancing 5-hydroxytryptophan (5-HTP) exposure" was invented by Jacob Pade Ramsoe Jacobsen (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A gastroretentive, sustained-release dosage form including 5-hydroxytryptophan (5-HTP) as an active ingredient and low-dose carbidopa is described. For example, the dosage form can be provided as a bilayer tablet comprising a swelling layer and a modified release layer, where the 5-HTP and carbidopa are both included in the modified release layer. The dosage form provides for essentially para...